<DOC>
	<DOC>NCT01527370</DOC>
	<brief_summary>This study will determine if ZOSTAVAX™ is safe, tolerable, and immunogenic in healthy adults in India.</brief_summary>
	<brief_title>Safety, Tolerability, and Immunogenicity of Zoster Vaccine Live (ZOSTAVAX™) in Healthy Adults in India (V211-025)</brief_title>
	<detailed_description />
	<mesh_term>Herpes Zoster</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>No fever on day of vaccination Females have a negative pregnancy test and use an acceptable method of birth control, or are postmenopausal Underlying chronic illnesses must be stable History of hypersensitivity reaction to any vaccine component Prior receipt of a varicella or zoster vaccine Prior history of herpes zoster Have recently had another vaccination Have recently received blood products other than autologous blood transfusion Pregnant or breast feeding Use of immunosuppressive therapy Known or suspected immune dysfunction Use of nontopical antiviral therapy with activity against herpesvirus</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>